When to achieve complete revascularization in infarct-related cardiogenic shock
Acute myocardial infarction (AMI) complicated by cardiogenic shock (CS) is a life-
threatening condition frequently encountered in patients with multivessel coronary artery …
threatening condition frequently encountered in patients with multivessel coronary artery …
Multivessel spontaneous coronary artery dissection: clinical features, angiographic findings, management, and outcomes
J Salamanca, M García-Guimarães, M Sabaté… - International Journal of …, 2023 - Elsevier
Background Spontaneous coronary artery dissection (SCAD) is a rare cause of acute
coronary syndrome. Multivessel (MV) SCAD is a challenging clinical presentation that might …
coronary syndrome. Multivessel (MV) SCAD is a challenging clinical presentation that might …
Immediate versus staged complete revascularization in acute coronary syndrome: A meta-analysis of randomized controlled trials
K Bujak, R Rinaldi, P Vidal-Cales, RA Montone… - International Journal of …, 2023 - Elsevier
Background Clinical guidelines recommend a complete revascularization (CR) in patients
with acute coronary syndromes (ACS) and multivessel disease (MVD). However, its optimal …
with acute coronary syndromes (ACS) and multivessel disease (MVD). However, its optimal …
Timing of multivessel revascularization in stable patients with STEMI: a systematic review and network meta-analysis
F Voll, C Kuna, M Scalamogna, T Kessler… - Revista Española de …, 2024 - Elsevier
Introduction and objectives: Multivessel percutaneous coronary intervention (MV-PCI) is
recommended in patients with ST-segment elevation myocardial infarction (STEMI) and …
recommended in patients with ST-segment elevation myocardial infarction (STEMI) and …
[HTML][HTML] Outcomes of patients with myocardial infarction and cardiogenic shock treated with culprit vessel-only versus multivessel primary PCI
O Hlinomaz, Z Motovska, P Kala, M Hromadka… - Hellenic Journal of …, 2024 - Elsevier
Introduction and objectives Multivessel primary percutaneous coronary intervention (pPCI) is
still often used in patients with ST-elevation myocardial infarction (STEMI) and cardiogenic …
still often used in patients with ST-elevation myocardial infarction (STEMI) and cardiogenic …
Multivessel vs. culprit-only percutaneous coronary intervention strategy in older adults with acute myocardial infarction
Background The optima revascularization strategy for senior patients admitted with acute
myocardial infarction (AMI) in the context of multivessel coronary artery disease (MVCAD) …
myocardial infarction (AMI) in the context of multivessel coronary artery disease (MVCAD) …
[HTML][HTML] Long-term clinical outcomes in patients with non-ST-segment Elevation Acute Coronary Syndrome and ST-segment elevation myocardial infarction with …
BRA Aarts, FTW Groenland, J Elscot, T Neleman… - IJC Heart & …, 2023 - Elsevier
Abstract Background Thrombolysis in Myocardial Infarction (TIMI) 0 flow often characterizes
ST-segment Elevation Myocardial Infarction (STEMI) patients, but may also feature in non …
ST-segment Elevation Myocardial Infarction (STEMI) patients, but may also feature in non …
The impact of on-site cardiac surgical backup on clinical outcomes of acute coronary syndrome—analysis of the ACSIS national registry
G Moady, T Ovdat, R Rubinshtein, A Eitan… - Frontiers in …, 2023 - frontiersin.org
Background The availability of advanced technologies for mechanical support in hospitals
with on-site cardiac surgery (CS), along with the ability to perform urgent coronary artery …
with on-site cardiac surgery (CS), along with the ability to perform urgent coronary artery …
Complete Revascularization in Non–ST-Segment Elevation Acute Coronary Syndrome: For Now, Just Do It
P Clemmensen, E Cavus, S Blankenberg - Cardiovascular Interventions, 2024 - jacc.org
(ACS) ranges from unstable angina to myocardial infarction (MI) and even patients
presenting in cardiogenic shock. The majority of patients in clinical practice are presenting …
presenting in cardiogenic shock. The majority of patients in clinical practice are presenting …
[PDF][PDF] 糖化清蛋白, 高敏C 反应蛋白与冠心病临界病变患者冠脉斑块形态学特征的关系及对功能性心肌缺血的预测研究
吕萍， 王慧敏， 黎叶飞， 曹牡华… - Progress in Modern …, 2023 - biomed.cnjournals.com
摘要目的: 分析糖化清蛋白, 高敏C 反应蛋白与冠心病临界病变患者冠脉斑块形态学特征的关系
及对功能性心肌缺血的预测价值. 方法: 选择自2020 年1 月至2022 年6 月我院经冠脉造影确诊 …
及对功能性心肌缺血的预测价值. 方法: 选择自2020 年1 月至2022 年6 月我院经冠脉造影确诊 …